期刊文献+

应用NCCLS EP10-A2文件对五种半胱氨酸蛋白酶抑制剂C试剂进行初步评价 被引量:3

Preliminary function evaluation on five kinds of cystatin C reagent kits according to NCCLS EP10-A2 document
下载PDF
导出
摘要 目的对五个厂家的半胱氨酸蛋白酶抑制剂C(胱抑素C)试剂检测性能进行初步评价。方法按照美国临床实验室标准化委员会(NCCLS)EP10-A2文件,使用五种试剂分别对胱抑素C低值、中值、高值标本进行检测,计算偏倚、总不精密度及其截距、斜率、携带污染、非线性、漂移性,并判断其临床可接受性。结果五个厂家的试剂总不精密度均在允许范围内,截距、非线性、漂移性均差异无统计学意义;利德曼试剂测定值偏倚大于允许偏倚,其余四个厂家试剂偏倚在允许范围内;科华、景源、迈克、美康的试剂存在携带污染。结论科华、景源、迈克、美康胱抑素C试剂盒准确度和精密度良好,试剂稳定,性能指标基本符合临床要求,但携带污染还有待进一步改进。 Objective To preliminarily evaluate the performance of five kinds of cystatin(Cys C) reagent kits.Methods According to the protocol EP10-A2 provided by National Committee for Clinical laboratory Standards(NCCLS),samples with low,middle or high level of Cys C were detected by five kinds of reagent kits.The bias,total imprecision,intercepts,slope rates,nonlinearities,carry-over rate and drifts were calculated and compared with the range of set value to assess clinical acceptability.Results Total imprecision of the five kinds of reagent kits were all within allowed range.No significant difference was showed in intercepts,nonlinearities and drifts.Bias of LEADMAN reagent exceeded permissive ranges,and bias of the others four kinds of reagents were within allowed range.Carry-over could be demonstrated in reagent kits of KEHUA,JINGYUAN,MAKER and MEIKANG.Conclusion Cys C reagent kits of KEHUA,MAKER,MEIKANG and JINGYUAN might be with fine accuracy,precision and stability,and consistent with clinical application requirements,but more attention should be paid for carry-over.
出处 《国际检验医学杂志》 CAS 2012年第2期157-159,共3页 International Journal of Laboratory Medicine
关键词 试剂盒 诊断 半胱氨酸蛋白酶抑制剂 评价 EP10-A2 reagent kits diagnostic cysteine proteinase inhibitors evaluation EP10-A2
  • 相关文献

参考文献12

二级参考文献23

共引文献135

同被引文献24

  • 1徐国宾,蒋琳.临床生物化学常规定量方法的分析性能评价[J].中华检验医学杂志,2007,30(6):718-720. 被引量:58
  • 2杨有业,张秀明.临床检验方法学评价[M].北京:人民卫生出版社,2008:118-127.
  • 3冯仁峰.临床检验质量管理技术基础[M].上海:上海科学技术文献出版社,2007:37.
  • 4张秀明,温冬梅,袁勇.临床生物化学检验质量管理与标准操作程序[M].北京:人民军医出版社,2007:103.
  • 5杨振华主编.临床实验室质量管理[M].北京:人民卫生出版社,2004,109—110.
  • 6National Committee for Clinical Laboratory Standards.Preliminary Evaluation of Quantitative Clinical Laboratory Methods;Approved Guideline[S].EP10-A2.NCCLS,2002.
  • 7NCCLS, EP10-A2. Preliminary evaluation of quantitative clinical laboratory methodsES] ,2002.
  • 8钟兰,林瑜,蔡玉玲.Dia Sys公司抗链球菌溶血素O与类风湿因子试剂性能评价[J].临床检验杂志,2007,25(6):412-412. 被引量:1
  • 9NCCI.S. EP10-A2 Preliminary Evaluation of Quantitative Clinical Laboratory MethodsES. Approved Guideline EP10-A2. 2002.
  • 10齐长福.载脂蛋白A1与载脂蛋白B液体双试剂性能评价[J].检验医学与临床,2009,6(2):110-111. 被引量:3

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部